CLINICAL_TRIALS
trial_result
· 2017-04-12
Clinical Trial Update: Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer [Phase 2]
Summary
Open-label Phase 2 study of sipuleucel-T in metastatic prostate cancer completed; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dendreon | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-12